Anna-Karin Maltais

Company: XNK Therapeutics

Job title: Chief Scientific Officer

Seminars:

Case Study: Harnessing Autologous NK Cells for Personalised Immunotherapy 5:00 pm

Engineering vs non-engineering strategies Important aspects of repeat dosing Strategies to increase cell potency, targeting and persistenceRead more

day: Conference Day One